FDA-Drug2026-09-02Class IICHEMICAL

Accord Healthcare Levothyroxine Sodium 175 mcg tablets recalled for subpotency

LABEL MIX UPNationwide distributionDrugs

What this means

Accord Healthcare is recalling specific lots of Levothyroxine Sodium Tablets 175 mcg because they may contain less active ingredient than labeled. Levothyroxine is a thyroid hormone replacement medication, and tablets that are weaker than expected could result in inadequate treatment of thyroid conditions.

  • Check if your levothyroxine matches the recalled lot numbers and expiration dates listed in the recall notice.
  • Do not stop taking your medication without talking to your doctor or pharmacist.
  • Contact your pharmacist or doctor if you have one of the affected lots to discuss next steps.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Subpotent Drug

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States
Affected count
N/A
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Products
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-count bottles (NDC 16729-456-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0784-2026

More Accord Healthcare recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.